Qiagen NV (QGEN)
42.78
+0.45
(+1.06%)
USD |
NYSE |
Nov 22, 16:00
42.79
+0.01
(+0.02%)
After-Hours: 20:00
Qiagen Debt to Equity Ratio: 0.5439 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.5439 |
| June 30, 2024 | 0.4116 |
| March 31, 2024 | 0.4176 |
| December 31, 2023 | 0.3965 |
| September 30, 2023 | 0.4015 |
| June 30, 2023 | 0.5211 |
| March 31, 2023 | 0.5279 |
| December 31, 2022 | 0.537 |
| September 30, 2022 | 0.6879 |
| June 30, 2022 | 0.5897 |
| March 31, 2022 | 0.5999 |
| December 31, 2021 | 0.6271 |
| September 30, 2021 | 0.6438 |
| June 30, 2021 | 0.6514 |
| March 31, 2021 | 0.6769 |
| December 31, 2020 | 0.6872 |
| September 30, 2020 | 0.6595 |
| June 30, 2020 | 0.6509 |
| March 31, 2020 | 0.6873 |
| December 31, 2019 | 0.6727 |
| September 30, 2019 | 0.714 |
| June 30, 2019 | 0.6702 |
| March 31, 2019 | 0.671 |
| December 31, 2018 | 0.8251 |
| September 30, 2018 | 0.6996 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.6983 |
| March 31, 2018 | 0.6867 |
| December 31, 2017 | 0.692 |
| September 30, 2017 | 0.6807 |
| June 30, 2017 | 0.5523 |
| March 31, 2017 | 0.441 |
| December 31, 2016 | 0.4093 |
| September 30, 2016 | 0.4012 |
| June 30, 2016 | 0.4091 |
| March 31, 2016 | 0.4038 |
| December 31, 2015 | 0.4088 |
| September 30, 2015 | 0.4205 |
| June 30, 2015 | 0.4142 |
| March 31, 2015 | 0.4245 |
| December 31, 2014 | 0.4423 |
| September 30, 2014 | 0.4304 |
| June 30, 2014 | 0.4281 |
| March 31, 2014 | 0.43 |
| December 31, 2013 | 0.3115 |
| September 30, 2013 | 0.3175 |
| June 30, 2013 | 0.3273 |
| March 31, 2013 | 0.3158 |
| December 31, 2012 | 0.312 |
| September 30, 2012 | 0.2467 |
| June 30, 2012 | 0.2512 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3965
Minimum
Dec 2023
0.6879
Maximum
Sep 2022
0.5796
Average
0.6135
Median
Debt to Equity Ratio Benchmarks
| LENZ Therapeutics Inc | -- |
| Oruka Therapeutics Inc | -- |
| Boston Scientific Corp | 0.5254 |
| Merus NV | 0.00 |
| uniQure NV | 0.9157 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.270B |
| Total Liabilities (Quarterly) | 2.740B |
| Shareholders Equity (Quarterly) | 3.530B |
| Current Ratio | 2.174 |
| Net Debt Paydown Yield | -0.06% |